0001209191-21-049380.txt : 20210803 0001209191-21-049380.hdr.sgml : 20210803 20210803165947 ACCESSION NUMBER: 0001209191-21-049380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20210803 DATE AS OF CHANGE: 20210803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamb Lawrence CENTRAL INDEX KEY: 0001830059 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39692 FILM NUMBER: 211140740 MAIL ADDRESS: STREET 1: C/O IN8BIO, INC. STREET 2: 79 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IN8BIO, INC. CENTRAL INDEX KEY: 0001740279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (646) 600-6438 MAIL ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Incysus Therapeutics, Inc. DATE OF NAME CHANGE: 20180510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-03 0 0001740279 IN8BIO, INC. INAB 0001830059 Lamb Lawrence C/O IN8BIO, INC. 79 MADISON AVENUE NEW YORK NY 10016 0 1 0 0 EVP and CSO Employee Stock Option (right to buy) 1.0685 2021-08-03 4 A 0 22082 0.00 A 2031-08-03 Common Stock 22082 83582 D All of the shares subject to the option shall vest on the date six months after August 3, 2021, subject to the Reporting Person continuing to provide service through such date. /s/ Jason Minio, Attorney-in-Fact 2021-08-03